![Impel Pharmaceuticals](https://gocience.com/logos/new/be325031af4942005ebb185c008f0e504ef3909f980f6980a8fa0e60fb11b588.jpg)
Impel Pharmaceuticals
Pharmaceuticals, 201 Elliott Ave W, Seattle, Washington, 98119, United States, 51-200 Employees
Phone Number: 12*********
Who is IMPEL PHARMACEUTICALS
Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to ...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: 201 Elliott Ave W, Seattle, Washington, 98119, United States
-
Date Founded: 2008
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
-
CEO: Adrian Adams
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from IMPEL PHARMACEUTICALS
Impel Pharmaceuticals Org Chart and Mapping
Similar Companies to Impel Pharmaceuticals
AbbVie
-
10001+
-
$ 1 Billion and Over
Apellis Pharmaceuticals
-
501-1000
-
$ 50 Million to 100 Million
Biohaven
-
201-500
-
$ 250 Million to 500 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Impel Pharmaceuticals
Answer: Impel Pharmaceuticals's headquarters are located at 201 Elliott Ave W, Seattle, Washington, 98119, United States
Answer: Impel Pharmaceuticals's phone number is 12*********
Answer: Impel Pharmaceuticals's official website is https://impelpharma.com
Answer: Impel Pharmaceuticals's revenue is $25 Million to $50 Million
Answer: Impel Pharmaceuticals's SIC: 2834
Answer: Impel Pharmaceuticals's NAICS: 325412
Answer: Impel Pharmaceuticals has 51-200 employees
Answer: Impel Pharmaceuticals is in Pharmaceuticals
Answer: Impel Pharmaceuticals top competitors include: AbbVie , Apellis Pharmaceuticals , Biohaven
Answer: Impel Pharmaceuticals contact info: Phone number: 12********* Website: https://impelpharma.com
Answer: Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Companys proprietary Precision Olfactory Delivery (POD) technology with well-established therapeutics.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month